Pharma companies on standby for flu jabs

Toronto News.Net
Sunday 28th June, 2009

GlaxoSmithKline and Roche, two major pharmaceutical companies, have had sizeable sales increases during the first quarter of 2009.

A lot of the money has come from people wishing to protect themselves from the swine flu epidemic.

Driven in part by the outbreak of avian flu in 2006, countries have been releasing treatments of anti-virals which can also be used to fight swine flu, officially known as the H1N1 virus.

Relenza and Tamiflu sales have already increased profits massively for Relenza and Roche.

Email this story to a friend

Have your say on this story